For example, HepG2 is not suitable for studying autoreactivity against some targets whose expression are weakened in this cell line [e.g. cytochrome P450 2D6, the target of LKM1 autoantibody identified in AIH patients (28)]. This evidence concerns the gene CYP2D6 and autoimmune hepatitis.